1. Home
  2. GRWG vs ELUT Comparison

GRWG vs ELUT Comparison

Compare GRWG & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

HOLD

Current Price

$1.51

Market Cap

96.3M

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.67

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRWG
ELUT
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.3M
23.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GRWG
ELUT
Price
$1.51
$0.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$2.50
$7.00
AVG Volume (30 Days)
1.1M
570.2K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$161,356,000.00
$21,746,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.82
$0.50
52 Week High
$2.40
$3.87

Technical Indicators

Market Signals
Indicator
GRWG
ELUT
Relative Strength Index (RSI) 44.01 55.24
Support Level $1.45 $0.52
Resistance Level $2.40 $0.73
Average True Range (ATR) 0.17 0.08
MACD -0.04 0.02
Stochastic Oscillator 7.89 79.13

Price Performance

Historical Comparison
GRWG
ELUT

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: